CS
OM icon

Candriam SCA’s Outset Medical OM Stock Holding History

Candriam SCA’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,328
Closed -$3.23M – 915
2022
Q4 		$3.23M Sell
8,328
-2,064
-20% -$582K 0.02% 481
2022
Q3 		$2.48M Buy
10,392
+2,495
+32% +$668K 0.02% 539
2022
Q2 		$1.76M Hold
7,897
– – 0.01% 529
2022
Q1 		$5.38M Sell
7,897
-7
-0.1% -$4.21K 0.04% 339
2021
Q4 		$5.46M Hold
7,904
– – 0.03% 350
2021
Q3 		$5.86M Buy
7,904
+2,067
+35% +$1.41M 0.04% 368
2021
Q2 		$4.38M Buy
5,837
+2,414
+71% +$1.85M 0.03% 432
2021
Q1 		$2.8M Hold
3,423
– – 0.02% 467
2020
Q4 		$2.92M Buy
+3,423
New +$2.64M 0.02% 478

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

Candriam SCA's OM Position: Q1 2023 in Review

Candriam SCA sold out of Outset Medical (OM) in Q1 2023, closing a stake of 8,328 shares — an estimated $3.23M sold.

Candriam SCA first reported a position in OM in Q4 2020 and held it in 9 quarters. The position peaked at $5.86M in Q3 2021. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

  • Candriam SCA reported no remaining Outset Medical position as of Q1 2023 after selling out during the quarter.
  • Candriam SCA sold 8,328 Outset Medical shares in Q1 2023, an estimated $3.23M.
  • Candriam SCA first reported a position in Outset Medical in Q4 2020 and held it in 9 quarters.
  • Candriam SCA's Outset Medical position peaked at $5.86M in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.